No Data
No Data
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) CEO For Now
Key Insights Eton Pharmaceuticals' Annual General Meeting to take place on 11th of June Salary of US$591.9k is part of CEO Sean Brynjelsen's total remuneration The overall pay is 103% above the in
Eton Pharmaceuticals Q1 2024 GAAP EPS $(0.03) Beats $(0.07) Estimate, Sales $7.966M Miss $8.000M Estimate
Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.07) by 57.14 percent. This is a 70 percent increase over losses of $(
Eton Pharmaceutical | 10-Q: Quarterly report
Eton Pharmaceuticals Expects Continued Sales Growth to Result in Positive Operating Cash Flow Throughout 2024 >ETON
Eton Pharmaceuticals Expects Continued Sales Growth to Result in Positive Operating Cash Flow Throughout 2024 >ETON
Earnings Flash (ETON) ETON PHARMACEUTICALS Posts Q1 Revenue $8M, Vs. Street Est of $8M
04:06 PM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (ETON) ETON PHARMACEUTICALS Posts Q1 Revenue $8M, vs. Street Est of $8M
Eton Pharmaceuticals 1Q Loss/Shr 3c >ETON
Eton Pharmaceuticals 1Q Loss/Shr 3c >ETON